Geneoscopy is a life sciences company in Missouri that works in the biopharma sector. Its filings show it is lobbying to expand access to colorectal cancer screening, including Medicare and commercial coverage, alignment with U.S. Preventive Services Task Force (USPSTF) screening guidelines, and related Medicare quality measures and appropriations for veterans. It has reported $110,000 in lobbying across four filings and used Venable LLP.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BART STUPAK
The latest disclosures for this client.
VENABLE LLP
2AVENABLE LLP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
VENABLE LLP
CAROLINE OLSEN
VENABLE LLP
DEEPTI LOHARIKAR
VENABLE LLP
ILISA HALPERN PAUL
VENABLE LLP
JAMES REILLY
VENABLE LLP
JOSHUA H RAYMOND
VENABLE LLP
mr JOHN V. DRZEWICKI
VENABLE LLP
mr RICHARD JOSEPH WARD iii
VENABLE LLP
VENABLE LLP
Q1VENABLE LLP
Q4VENABLE LLP
Q3VENABLE LLP
Q2VENABLE LLP
Q1